Synaptotagmin-1, a presynaptic transmembrane protein essential for hippocampal neurotransmitter release, exhibits significantly increased CSF levels in patients with AD dementia and even mild cognitive impairment due to AD or preclinical AD compared to controls [124, 125]. This evidence concerns the gene SYT1 and Alzheimer disease.